CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy

Donor lymphocyte infusion (DLI) followed by hematopoietic stem cell transplantation has served as an effective prevention/treatment modality against the relapse of some hematologic tumors, such as chronic myeloid leukemia (CML). However, the therapeutic efficacies of DLI for other types of leukemia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyung Bae, Lee, Ji Eun, Oh, Yu Mi, Lee, Sang Jin, Eom, Hyeon-Seok, Choi, Kyungho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565951/
https://www.ncbi.nlm.nih.gov/pubmed/28751785
http://dx.doi.org/10.1038/emm.2017.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565951/
https://www.ncbi.nlm.nih.gov/pubmed/28751785
http://dx.doi.org/10.1038/emm.2017.104

Ejemplares similares